@article{f31cca28d8014dd0877befe4bd55c4c5,
title = "Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non-histaminergic angioedema",
keywords = "Angioedema/drug therapy, Angioedemas, Hereditary, Bradykinin, Complement C1 Inactivator Proteins, Complement C1 Inhibitor Protein/therapeutic use, Esterases, Humans, Urticaria",
author = "{Alizadeh Aghdam}, Mehran and Hofman, {Zonne L.M.} and Michelle Meertens and Ans Lebens and Hack, {C. Erik} and Knulst, {Andr{\'e} C.} and Coen Maas and Heike R{\"o}ckmann",
note = "Funding Information: This study is financed in part by Pharming Group N.V. ",
year = "2022",
month = dec,
doi = "10.1111/all.15437",
language = "English",
volume = "77",
pages = "3673--3676",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley-Blackwell",
number = "12",
}